Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer

被引:7
|
作者
Narita, Yuki [1 ]
Kato, Takahiro [1 ,2 ]
Takemasa, Kimihiro [1 ]
Sato, Hiroki [1 ]
Ikeda, Tomohiro [1 ]
Harada, Takaomi [1 ]
Oyama, Sho [1 ]
Murakami, Masao [3 ]
机构
[1] Southern Tohoku Proton Therapy Ctr, Dept Radiat Phys & Technol, 172 Yatsuyamada 7 Chome, Koriyama, Fukushima 9638563, Japan
[2] Fukushima Med Univ, Sch Hlth Sci, Fukushima, Japan
[3] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, Fukushima, Japan
来源
关键词
gastrointestinal tract; pancreatic cancer; proton therapy; simultaneous integrated boost; CARBON ION RADIOTHERAPY; BEAM; GEMCITABINE;
D O I
10.1002/acm2.13429
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To investigate the dosimetric impact of changes in the large bowel content during proton therapy (PT) with simultaneous integrated boost (SIB) for locally advanced pancreatic cancer (LAPC). Materials and methods Fifteen patients with LAPC were included in this study. The SIB method was performed using five fields according to our standard protocol. A total dose of 67.5 Gy(relative biological effectiveness [RBE]) was prescribed in 25 fractions using the SIB method. A dose of 45 Gy(RBE) was prescribed for the entire planning target volume (PTV) by using four main fields. The remaining 22.5 Gy(RBE) was prescribed to the PTV excluding for the gastrointestinal tract using one subfield. Five simulated doses were obtained by the forward dose calculations with the Hounsfield units (HU) override to the large bowel to 50, 0, -100, -500, and -1000, respectively. The dose-volume indices in each plan were compared using the 50 HU plan as a reference. Results At D-98 of the clinical target volume (CTV) and spinal cord-D-2cc, when the density of the large bowel was close to that of gas, there were significant differences compared to the reference plan (p < 0.05). By contrast, no significant difference was observed in stomach-D-2cc duodenum-D-2cc, small bowel-D-2cc, kidneys-V-18, and liver-D-mean under any of the conditions. There were no cases in which the dose constraint of organs at risk, specified by our institution, was exceeded. Conclusion Density change in the large bowel was revealed to significantly affect the doses of the CTV and spinal cord during PT with SIB for LAPC. For beam arrangement, it is important to select a gantry angle that prevents the large bowel from passing as much as possible. If this is unavoidable, it is important to carefully observe the gas image on the beam path during daily image guidance and to provide adaptive re-planning as needed.
引用
收藏
页码:90 / 98
页数:9
相关论文
共 50 条
  • [21] Proton versus photon therapy in locally advanced cervical cancer; a dosimetric study
    Abdulwahid, D.
    Lines, D.
    Stich, P.
    Lee, J.
    Barraclough, L.
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S800 - S800
  • [22] Preoperative VMAT with simultaneous integrated boost for locally advanced distal rectal cancer
    Yang, Y.
    Liu, Q.
    Zhao, P.
    Qian, J.
    Peng, Q.
    Zhu, Y.
    Feng, L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S785 - S786
  • [23] Dosimetric impact of edema on inguinal lymph node boost in locally advanced vulvar cancer
    Mohamed, Sandy
    Fokdal, Lars
    Assenholt, Marianne S.
    Kallehauge, Jesper
    Lindegaard, Jacob C.
    Tanderup, Kari
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (10): : 315 - 319
  • [24] A Dosimetric Study of Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost for Rectal Cancer
    Sun, T.
    Lin, X.
    Yin, Y.
    Liu, T.
    MEDICAL PHYSICS, 2015, 42 (06) : 3337 - 3337
  • [25] Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer
    Gawish, Ahmed
    Eberle, Fabian
    Schymalla, Markus
    Vorwerk, Hilke
    Adeberg, Sebastian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2281 - S2283
  • [26] Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer
    Gawish, Ahmed
    Eberle, Fabian
    Vorwerk, Hilke
    Adeberg, Sebastian
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 238 - 238
  • [27] Prediction of Dosimetric Variation in Dominant Intraprostatic Lesion with Simultaneous Integrated Boost for Pencil Beam Proton Therapy
    Chang, C.
    Bohannon, D.
    Stiles, K.
    Stanforth, A.
    Tian, S.
    Wang, Y.
    Lin, L.
    Patel, P.
    Liu, T.
    Yang, X.
    Zhou, J.
    MEDICAL PHYSICS, 2020, 47 (06) : E434 - E434
  • [28] Proton Beam Therapy for Locally Advanced Breast Cancer: Dosimetric Results and Acute Toxicity
    Hartsell, W. F.
    Dorn, P. L.
    McGee, L. A.
    Schmidt, S. L.
    Hartsell, S. O.
    Kaplan, D.
    Pankuch, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S273 - S273
  • [29] Dosimetric impact of bowel filling during proton therapy for paediatric abdominal neuroblastoma
    Ghica, A.
    Botnariuc, D.
    Hussein, M.
    Rompokos, V.
    D'Souza, D.
    Gaze, M.
    Gains, J.
    Lim, P.
    Veiga, C.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S285 - S287
  • [30] The Effect of Changes in the Content of Air in the Small Bowel On Dose Distributions in Proton and Photon Therapy for Pancreatic Cancer
    Ingram, M.
    Kassaee, A.
    McDonough, J.
    Metz, J.
    Weilliver, M.
    MEDICAL PHYSICS, 2008, 35 (06)